199 related articles for article (PubMed ID: 25685162)
1. The efficacy and safety of the Timothy grass allergy sublingual immunotherapy tablet in Canadian adults and children.
Hébert J; Blaiss M; Waserman S; Kim H; Creticos P; Maloney J; Kaur A; Li Z; Nelson H; Nolte H
Allergy Asthma Clin Immunol; 2014; 10(1):53. PubMed ID: 25685162
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of ragweed sublingual immunotherapy in Canadian patients with allergic rhinoconjunctivitis.
Kim H; Waserman S; Hébert J; Blaiss M; Nelson H; Creticos P; Kaur A; Maloney J; Li Z; Nolte H
Allergy Asthma Clin Immunol; 2014; 10(1):55. PubMed ID: 25788949
[TBL] [Abstract][Full Text] [Related]
3. Safety of sublingual immunotherapy Timothy grass tablet in subjects with allergic rhinitis with or without conjunctivitis and history of asthma.
Maloney J; Durham S; Skoner D; Dahl R; Bufe A; Bernstein D; Murphy K; Waserman S; Berman G; White M; Kaur A; Nolte H
Allergy; 2015 Mar; 70(3):302-9. PubMed ID: 25495666
[TBL] [Abstract][Full Text] [Related]
4. Lack of effect of Timothy grass pollen sublingual immunotherapy tablet on birch pollen-induced allergic rhinoconjunctivitis in an environmental exposure unit.
Ellis AK; Tenn MW; Steacy LM; Adams DE; Day AG; Walker TJ; Nolte H
Ann Allergy Asthma Immunol; 2018 May; 120(5):495-503.e2. PubMed ID: 29432967
[TBL] [Abstract][Full Text] [Related]
5. Randomized controlled trial of ragweed sublingual immunotherapy tablet in the subpopulation of Canadian children and adolescents with allergic rhinoconjunctivitis.
Ellis AK; Gagnon R; Bernstein DI; Nolte H
Allergy Asthma Clin Immunol; 2021 Dec; 17(1):127. PubMed ID: 34886880
[TBL] [Abstract][Full Text] [Related]
6. Safety of Timothy Grass Sublingual Immunotherapy Tablet in Children: Pooled Analyses of Clinical Trials.
Halken S; Roberts G; Valovirta E; Nolte H; Hulstrøm V; Blaiss MS
J Allergy Clin Immunol Pract; 2020 Apr; 8(4):1387-1393.e2. PubMed ID: 31954191
[TBL] [Abstract][Full Text] [Related]
7. A phase 3 trial assessing the efficacy and safety of grass allergy immunotherapy tablet in subjects with grass pollen-induced allergic rhinitis with or without conjunctivitis, with or without asthma.
Murphy K; Gawchik S; Bernstein D; Andersen J; Pedersen MR
J Negat Results Biomed; 2013 Jun; 12():10. PubMed ID: 23725348
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of grass sublingual immunotherapy tablet, MK-7243: a large randomized controlled trial.
Maloney J; Bernstein DI; Nelson H; Creticos P; Hébert J; Noonan M; Skoner D; Zhou Y; Kaur A; Nolte H
Ann Allergy Asthma Immunol; 2014 Feb; 112(2):146-153.e2. PubMed ID: 24468255
[TBL] [Abstract][Full Text] [Related]
9. Sublingual immunotherapy tablets in monosensitized and polysensitized adults with allergic rhinoconjunctivitis.
Nelson HS; Bernstein DI; Biedermann T; Nolte H
Allergy Asthma Proc; 2024 Jan; 45(1):33-36. PubMed ID: 38151733
[No Abstract] [Full Text] [Related]
10. Efficacy and Safety of Ragweed SLIT-Tablet in Children with Allergic Rhinoconjunctivitis in a Randomized, Placebo-Controlled Trial.
Nolte H; Bernstein DI; Nelson HS; Ellis AK; Kleine-Tebbe J; Lu S
J Allergy Clin Immunol Pract; 2020; 8(7):2322-2331.e5. PubMed ID: 32304832
[TBL] [Abstract][Full Text] [Related]
11. Treatment effect of sublingual immunotherapy tablets and pharmacotherapies for seasonal and perennial allergic rhinitis: Pooled analyses.
Durham SR; Creticos PS; Nelson HS; Li Z; Kaur A; Meltzer EO; Nolte H
J Allergy Clin Immunol; 2016 Oct; 138(4):1081-1088.e4. PubMed ID: 27527264
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of house dust mite sublingual immunotherapy tablet in North American adolescents and adults in a randomized, placebo-controlled trial.
Nolte H; Bernstein DI; Nelson HS; Kleine-Tebbe J; Sussman GL; Seitzberg D; Rehm D; Kaur A; Li Z; Lu S
J Allergy Clin Immunol; 2016 Dec; 138(6):1631-1638. PubMed ID: 27521719
[TBL] [Abstract][Full Text] [Related]
13. Clinical efficacy of 300IR 5-grass pollen sublingual tablet in a US study: the importance of allergen-specific serum IgE.
Cox LS; Casale TB; Nayak AS; Bernstein DI; Creticos PS; Ambroisine L; Melac M; Zeldin RK
J Allergy Clin Immunol; 2012 Dec; 130(6):1327-34.e1. PubMed ID: 23122534
[TBL] [Abstract][Full Text] [Related]
14. Sequential Treatment Initiation with Timothy Grass and Ragweed Sublingual Immunotherapy Tablets Followed by Simultaneous Treatment Is Well Tolerated.
Maloney J; Berman G; Gagnon R; Bernstein DI; Nelson HS; Kleine-Tebbe J; Kaur A; Li Q; Nolte H
J Allergy Clin Immunol Pract; 2016; 4(2):301-9.e2. PubMed ID: 26755098
[TBL] [Abstract][Full Text] [Related]
15. Timothy specific IgE levels are associated with efficacy and safety of timothy grass sublingual immunotherapy tablet.
Nolte M; Barber D; Maloney J; Li Z; Kaur A; Galan A; Andersen JS; Nolte H
Ann Allergy Asthma Immunol; 2015 Dec; 115(6):509-515.e2. PubMed ID: 26507709
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy With the SQ Tree SLIT-tablet in Adults and Adolescents With Allergic Rhinoconjunctivitis.
Mäkelä MJ; Gyllfors P; Valovirta E; Steffensen MA; Grønager PM; Savolainen J; Winther L
Clin Ther; 2018 Apr; 40(4):574-586.e4. PubMed ID: 29551533
[TBL] [Abstract][Full Text] [Related]
17. The SQ tree SLIT-tablet is highly effective and well tolerated: Results from a randomized, double-blind, placebo-controlled phase III trial.
Biedermann T; Kuna P; Panzner P; Valovirta E; Andersson M; de Blay F; Thrane D; Jacobsen SH; Stage BS; Winther L
J Allergy Clin Immunol; 2019 Mar; 143(3):1058-1066.e6. PubMed ID: 30654054
[TBL] [Abstract][Full Text] [Related]
18. Randomized controlled trial of ragweed allergy immunotherapy tablet efficacy and safety in North American adults.
Nolte H; Hébert J; Berman G; Gawchik S; White M; Kaur A; Liu N; Lumry W; Maloney J
Ann Allergy Asthma Immunol; 2013 Jun; 110(6):450-456.e4. PubMed ID: 23706715
[TBL] [Abstract][Full Text] [Related]
19. Immunologic effects and tolerability profile of in-season initiation of a standardized-quality grass allergy immunotherapy tablet: a phase III, multicenter, randomized, double-blind, placebo-controlled trial in adults with grass pollen-induced rhinoconjunctivitis.
Reich K; Gessner C; Kroker A; Schwab JA; Pohl W; Villesen H; Wüstenberg E; Emminger W
Clin Ther; 2011 Jul; 33(7):828-40. PubMed ID: 21741092
[TBL] [Abstract][Full Text] [Related]
20. Treatment of seasonal allergic rhinoconjunctivitis with a once-daily SQ-standardized grass allergy immunotherapy tablet.
Nelson H; Lehmann L; Blaiss MS
Curr Med Res Opin; 2012 Jun; 28(6):1043-51. PubMed ID: 22502864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
